Download Data Sheet ABILIFYTM - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
National Minimum Standards for Psychiatric …
napicu.org.uk1 National Minimum Standards for Psychiatric Intensive Care in General Adult Services Updated 2014
統合失調症について - www-yaku.meijo-u.ac.jp
www-yaku.meijo-u.ac.jp急性期統合失調症の症状と問題行動 一過性 周辺症状 一過性 周辺症状 持続性 中核症状 ※精神運動興奮・錯乱状態は、統合失調症の重症度とは無関係
DSM - asas.or.jp
www.asas.or.jp22 文献 1） Lehman AF, Lieberman JA, Dixon LB, et al：Practice guideline for the treatment of patients with schizophrenia, second edition.
表 第 章のまとめ - asas.or.jp
www.asas.or.jp95 ドン（2～6mg）が5 試験4, 7, 14-16）あり，Positive and Negative Syndrome Scale Excited Component（PANSS-EC）， Brief Psychiatric Rating Scale（BPRS）などの評価でいずれ も精神症状の改善を認めたが， 24 時間以内に評価が行われたものは9 試験であった4-9, 12, 14, 16）
Effects of Procyclidine on Eye Movements in …
www.philipcorr.netEffects of Procyclidine on Eye Movements in Schizophrenia Ulrich Ettinger1,2, Veena Kumari1,3, Elizabeth Zachariah1, Adrian Galea1, Trevor J Crawford4, Philip J Corr2, David Taylor5, Mrigendra Das1 and Tonmoy Sharma*,6 1Division of Psychological Medicine, Institute of Psychiatry, UK; 2Department of Psychology, Goldsmiths …
治療精神分裂症的新劑型藥物 - Paliperidone
www.taiwan-pharma.org.tw第26卷第4期 Dec. 31 2010 藥學雜誌 第105冊 79 治療精神分裂症的新劑型藥物 - Paliperidone 行政院衛生署桃園療養院藥師 鍾欣蓓、鄭淑文